Search Results
Moving to the frontline: gilteritinib plus chemo for newly diagnosed AML
Gilteritinib plus azacitidine versus azacitidine monotherapy for newly diagnosed FLT3-mutated AML
Gilteritinib combined with induction and consolidation chemotherapy in newly diagnosed AML patients
Patient-reported outcomes in FLT3-mutated AML patients treated with gilteritinib plus azacitidine
Crenolanib plus 7+3 chemotherapy in adults with newly diagnosed FLT3-mutated AML.
All about Gilteritinib in 49 seconds #AML #leukemia #cancer #AML
Selecting Therapy for Newly Diagnosed AML
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in patients with flt3-mutated re...
COMMODORE: gilteritinib for the treatment of R/R FLT3-mutated AML
Highlights in AML: quizartinib in elderly patients & in frontline FLT3-mutated AML
Azacitidine, venetoclax and gilteritinib for patients with FLT3-mutated acute myeloid leukaemia
Can gilteritinib cure AML? #AML